2023

Dual Stem Cell Treatment Targets Melanoma Brain Metastases in Mice

Overall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which harness the power of the immune system to attack cancer cells, have garnered excitement in recent years for their potential to revolutionize the treatment of metastatic melanomas, but results from early clinical studies indicate that the prognosis for most patients with brain metastatic disease remains poor.

Read More

BRAF Testing For Melanoma: Types, Procedure & Results

Melanoma is a type of skin cancer. It has become a significant global public health concern. The American Cancer Society predicts that approximately 97,610 new cases of Melanoma will be diagnosed in the United States in 2023, with more men than women affected. Early identification and effective management of this disease are crucial in improving the survival rates of people with Melanoma.

Read More
MRV News
Melanoma News
Archive
Menu